Thank you, Citeline Commercial, for your podcast interviewing our CEO and Co-Founder, Joel Morse, as well as our partners, Andy Molnar, CEO of Digital Therapeutics Alliance, and Owen McCarthy, CEO of MedRhythms, Inc.! Give the podcast a listen to hear the trio discuss the current situation surrounding #digitaltherapeutics, and where they believe they are headed in the coming years. #DTx #clinicalresearch #DCTs https://lnkd.in/gErsWZvJ
Curavit’s Post
More Relevant Posts
-
Chief Medical Officers from biotech companies Xalud Therapeutics, Inc., SparingVision, Altimmune, Inc.and Zai Lab joined us at the CMO Summit 360º in April to explain how they pitch to different investors and how their pitching methodology has evolved over time. Learn more valuable insights and lessons through this podcast. Listen to the podcast here: https://lnkd.in/gPNs6FmM #CMO #CMO360
To view or add a comment, sign in
-
When Capital Rx's Co-Founder & CEO, A. J. Loiacono, and Prime Therapeutics' CEO, Mostafa Kamal, recorded a special episode of The Astonishing Healthcare #podcast to discuss our alliance, they explained the unique benefits and capabilities JUDI® brings to market, as well as what this portends for the future of #pharmacybenefits. Watch the full episode of the podcast here: https://okt.to/FDhUu4
To view or add a comment, sign in
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/7wsG50SiuzB In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
To view or add a comment, sign in
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/tsHx50SiuAj In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
To view or add a comment, sign in
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/nLIX50Siuvs In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
To view or add a comment, sign in
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/VzWX50SiuzW In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
To view or add a comment, sign in
-
LISTEN NOW: In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, A. J. Loiacono, share the story behind the strategic alliance between their organizations and their vision to reimagine pharmacy. “We knew that platform modernization was going to be an important priority for us,” Kamal said. “And when we stacked the options, everything that’s available externally, internal build, it was a no brainer that the right partner for us was Capital Rx. When you think about the capabilities, the alignment around vision and mission and key principles, and it also helps that there’s a level of trust in our relationship as well.” Read more and listen to the full episode here: https://bit.ly/3TGWvPU
To view or add a comment, sign in
-
Analysis of #oligos can be challenging. Don't miss this informative webinar on #LCMS analysis to learn how to improve quantitation efficiency and success. #Pharmaron
Explore the latest episode of Pharmaron's #DMPK Insights: “It’s ‘All-go’ with Oligos: Challenges and Opportunities in LC-MS of Therapeutics.” Join experts Robert MacNeill, Professor Michael Bartlett and Dr. Guilherme (Gui) Guimaraes as they delve into the dynamic world of oligonucleotide LC-MS. Discover the key challenges, the critical importance of sensitivity in these assays, and the innovative analytical approaches and technologies being developed and used today. Don't miss this insightful discussion & listen to the podcast: https://lnkd.in/dYUSmmkd Learn more about Pharmaron DMPK services, here: https://lnkd.in/dCGMgYjK #DMPKinsights #Pharmaron #Podcast #Oligos
To view or add a comment, sign in
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/ITpu50Sm11S In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
Podcast: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
scrip.citeline.com
To view or add a comment, sign in
-
🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/L9Jp50SiuBf In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation
Podcast: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
scrip.citeline.com
To view or add a comment, sign in
3,001 followers